🇺🇸 Zynlonta in United States

Zynlonta (LONCASTUXIMAB) regulatory status in United States.

Marketing authorisation

FDA

  • Marketing authorisation holder: ADC Therapeutics SA
  • Status: approved

Zynlonta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is Zynlonta approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Zynlonta in United States?

ADC Therapeutics SA holds the US marketing authorisation.